Close



Mar 8, 2023 04:45PM
Nov 3, 2022 04:36PM
Aug 4, 2022 04:30PM
Aug 1, 2022 04:31PM
Aug 1, 2022 04:30PM
May 12, 2022 04:31PM
Mar 15, 2022 04:01PM Iovance Biotherapeutics’ Investigational New Drug Application (IND) Allowed to Proceed for TALEN®-Edited Tumor Infiltrating Lymphocyte (TIL) in Unresectable or Metastatic Melanoma and Stage III or
Mar 3, 2022 04:45PM
Jan 10, 2022 04:30PM
Aug 5, 2021 04:30PM
May 6, 2021 04:30PM
Mar 4, 2021 04:42PM
Nov 17, 2020 08:00PM
Nov 5, 2020 04:35PM Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2020
Aug 5, 2020 04:30PM
Jul 6, 2020 04:33PM
Jul 6, 2020 04:33PM
Apr 30, 2020 08:31AM
Mar 4, 2020 04:30PM
Jan 21, 2020 08:35AM
Jan 21, 2020 08:31AM Calyxt Issues Stockholder Letter
Jan 15, 2020 04:30PM
Jan 12, 2020 04:00PM
Nov 6, 2019 04:47PM
Nov 6, 2019 04:05PM
Oct 29, 2019 04:30PM
Oct 1, 2019 04:30PM
Aug 6, 2019 04:30PM Cellectis Reports Financial Results for Second Quarter and First Six Months 2019
May 7, 2019 05:30PM
May 7, 2019 04:32PM
Apr 17, 2019 04:30PM
Apr 2, 2019 04:32PM
Apr 2, 2019 04:30PM
Mar 11, 2019 04:10PM
Mar 11, 2019 04:10PM Calyxt Reports 4th Quarter and Full Year 2018 Financial Results
Mar 7, 2019 04:30PM
Feb 26, 2019 04:30PM
Nov 13, 2018 04:30PM
Sep 27, 2018 04:31PM
Sep 27, 2018 04:30PM
Sep 19, 2018 04:30PM
Aug 1, 2018 06:13PM Calyxt Reports Financial Results for Second Quarter and Half-Year 2018
Aug 1, 2018 04:30PM
Jun 4, 2018 04:31PM
Jun 4, 2018 04:30PM
May 22, 2018 07:59PM
May 22, 2018 04:30PM
May 7, 2018 04:30PM
May 2, 2018 04:30PM Cellectis Files IND for UCART22 in Acute Lymphoblastic Leukemia (B-ALL)
Mar 12, 2018 04:51PM

251,637 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All